These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 660467)

  • 41. Multiple pathways of propranolol's metabolism are inhibited by debrisoquin.
    Anthony L; Koshakji R; Wood AJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):297-300. PubMed ID: 2776392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased absorption as a possible cause for the lower bioavailability of a sustained-release propranolol.
    Takahashi H; Ogata H; Warabioka R; Kashiwada K; Ohira M; Someya K
    J Pharm Sci; 1990 Mar; 79(3):212-5. PubMed ID: 2338628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simple and rapid determination of propranolol and its active metabolite, 4-hydroxypropranolol, in human plasma by liquid chromatography with fluorescence detection.
    Albani F; Riva R; Baruzzi A
    J Chromatogr; 1982 Mar; 228():362-5. PubMed ID: 7076762
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.
    Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
    Eur J Clin Pharmacol; 1993; 44(5):489-92. PubMed ID: 8359189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of major sulfate conjugates in the metabolism of propranolol in dog and man.
    Walle T; Walle UK; Knapp DR; Conradi EC; Bargar EM
    Drug Metab Dispos; 1983; 11(4):344-9. PubMed ID: 6137341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct TLC resolution of atenolol and propranolol into their enantiomers using three different chiral selectors as impregnating reagents.
    Bhushan R; Tanwar S
    Biomed Chromatogr; 2008 Sep; 22(9):1028-34. PubMed ID: 18506901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved high-performance liquid chromatographic method for the simultaneous determination of propranolol and 4-hydroxypropranolol in plasma with fluorescence detection.
    Koshakji RP; Wood AJ
    J Chromatogr; 1987 Nov; 422():294-300. PubMed ID: 3437017
    [No Abstract]   [Full Text] [Related]  

  • 48. Online, Absolute Quantitation of Propranolol from Spatially Distinct 20- and 40-μm Dissections of Brain, Liver, and Kidney Thin Tissue Sections by Laser Microdissection-Liquid Vortex Capture-Mass Spectrometry.
    Cahill JF; Kertesz V; Weiskittel TM; Vavrek M; Freddo C; Van Berkel GJ
    Anal Chem; 2016 Jun; 88(11):6026-34. PubMed ID: 27214103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.
    Walle T; Conradi EC; Walle UK; Fagan TC; Gaffney TE
    Clin Pharmacol Ther; 1980 Jan; 27(1):22-31. PubMed ID: 7351114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple micromethod for simultaneous determination of plasma propranolol and 4-hydroxypropranolol.
    Rao PS; Quesada LC; Mueller HS
    Clin Chim Acta; 1978 Sep; 88(2):355-61. PubMed ID: 699330
    [No Abstract]   [Full Text] [Related]  

  • 51. Fluorimetric determination of norfloxacin in plasma and urine samples after thin-layer chromatographic separation.
    Warlich R; Krauss D; Mutschler E
    Arzneimittelforschung; 1989 Jun; 39(6):656-8. PubMed ID: 2775331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of diltiazem versus cimetidine on propranolol metabolism.
    Tateishi T; Ohashi K; Fujimura A; Ebihara A
    J Clin Pharmacol; 1992 Dec; 32(12):1099-104. PubMed ID: 1487547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Propranolol metabolism by Cunninghamella bainieri.
    Foster BC; Buttar HS; Qureshi SA; McGilveray IJ
    Xenobiotica; 1989 May; 19(5):539-46. PubMed ID: 2750210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic propranolol administration during pregnancy. Maternal pharmacokinetics.
    Smith MT; Livingstone I; Eadie MJ; Hooper WD; Triggs EJ
    Eur J Clin Pharmacol; 1983; 25(4):481-90. PubMed ID: 6653642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative analysis of naphthoxylactic acid, a major metabolite of propranolol in plasma in man.
    Easterling DE; Walle T; Conradi EC; Gaffney TE
    J Chromatogr; 1979 Mar; 162(3):439-45. PubMed ID: 528611
    [No Abstract]   [Full Text] [Related]  

  • 56. Urine and plasma propranolol.
    Andreasen F; Jakobsen P; Kornerup HJ; Pedersen EB; Pedersen OL
    Clin Pharmacol Ther; 1983 Jan; 33(1):10-8. PubMed ID: 6848294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silica gel high-performance liquid chromatography for the simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization.
    Wilson MJ; Walle T
    J Chromatogr; 1984 Oct; 310(2):424-30. PubMed ID: 6511860
    [No Abstract]   [Full Text] [Related]  

  • 58. Versatile isocratic high-performance liquid chromatographic assay for propranolol and its basic, neutral and acidic metabolites in biological fluids.
    Kwong EC; Shen DD
    J Chromatogr; 1987 Mar; 414(2):365-79. PubMed ID: 3571404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.
    Von Bahr C; Hermansson J; Tawara K
    Br J Clin Pharmacol; 1982 Jul; 14(1):79-82. PubMed ID: 7104170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.